Skip to main content
Equibles
MRNA logo

MRNA · Moderna, Inc. · Held by Funds

Track MRNA — free

Use MRNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$223.37 -7.98 (-3.45%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$90.38B
Shares
404.62M
Volume · Nov 13 8.09M Avg daily vol (3M) 21.79M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of MRNA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 19.78% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 4.04% 16,357,597
Index ETFs 15.74% 63,671,516
Active ETFs 0.90% 3,637,025
Active funds 15.63% 63,235,149
Unclassified 4.76% 19,249,694
All registered funds 41.06% 166,150,981
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding MRNA

678 fund positions
Fund Balance Value % of Fund Open
Growth Fund of America 14,983,229 $2,102,746,358 0.60%
Fidelity Growth Company Fund 8,239,175 $1,156,285,820 1.18%
VANGUARD TOTAL STOCK MARKET INDEX FUND 11,331,692 $793,558,391 0.03%
Fidelity 500 Index Fund 4,584,070 $643,328,384 0.07%
VANGUARD 500 INDEX FUND 9,154,510 $641,090,335 0.04%
VANGUARD INTERNATIONAL GROWTH FUND 4,297,329 $603,087,152 1.35%
VANGUARD SMALL-CAP INDEX FUND 8,190,072 $573,550,742 0.30%
VANGUARD SMALL-CAP VALUE INDEX FUND 5,187,970 $363,313,539 0.54%
iShares Core S&P 500 ETF 4,857,193 $340,149,226 0.04%
Fidelity Growth Company K6 Fund 2,370,154 $332,627,412 1.18%
Capital Group Growth ETF 2,316,671 $325,121,608 1.28%
Growth Fund 4,620,700 $323,587,621 0.57%
VANGUARD WELLINGTON FUND 2,296,120 $322,237,481 0.26%
Fidelity Contrafund 4,335,983 $303,648,889 0.17%
State Street(R) SPDR(R) S&P 500(R) ETF Trust 4,279,997 $299,728,190 0.04%
Fidelity OTC Portfolio 5,313,300 $291,275,106 0.68%
Fidelity Series Growth Company Fund 1,983,741 $278,398,212 1.14%
Fidelity Puritan Fund 1,770,500 $248,471,970 0.74%
Invesco S&P 500 Equal Weight ETF 4,051,567 $222,106,903 0.23%
Select Biotechnology Portfolio 1,564,429 $219,551,966 3.49%
iShares Biotechnology ETF 2,574,707 $180,306,731 1.98%
State Street(R) Health Care Select Sector SPDR(R) ETF 2,494,789 $174,710,074 0.43%
State Street(R) SPDR(R) S&P(R) Biotech ETF 2,164,892 $151,607,387 1.41%
Baron Partners Fund 1,989,386 $139,316,702 0.77%
Fidelity Advisor Equity Growth Fund 985,401 $138,291,176 1.07%
Schwab U.S. Mid-Cap ETF 976,841 $137,089,866 0.92%
VANGUARD INSTITUTIONAL INDEX FUND 1,916,229 $134,193,517 0.04%
VANGUARD HEALTH CARE FUND 2,345,644 $128,588,204 0.34%
VANGUARD HEALTH CARE INDEX FUND 880,131 $123,517,585 0.56%
Schwab U.S. Large-Cap Growth ETF 857,685 $120,367,513 0.19%
Select Health Care Portfolio 800,000 $112,272,000 1.66%
VANGUARD U.S. GROWTH FUND 781,392 $109,660,553 0.25%
Schwab Fundamental U.S. Large Company ETF 753,917 $105,804,712 0.38%
iShares Russell Mid-Cap ETF 1,494,264 $104,643,308 0.18%
T. Rowe Price Health Sciences Fund, Inc. 1,412,800 $98,938,384 0.83%
Fidelity Total Market Index Fund 674,346 $94,637,718 0.07%
Strategic Advisers U.S. Total Stock Fund 667,349 $93,655,759 0.09%
Strategic Advisers Fidelity U.S. Total Stock Fund 581,419 $81,596,342 0.03%
Fidelity Series Total Market Index Fund 550,731 $77,289,589 0.07%
Fidelity Mid Cap Index Fund 1,378,710 $75,580,882 0.15%
VIP Growth Portfolio 1,021,411 $71,529,412 0.57%
Fidelity Contrafund K6 944,799 $66,164,274 0.18%
Fidelity Balanced Fund 456,513 $64,067,034 0.10%
BlackRock Health Sciences Opportunities Portfolio 444,967 $62,446,669 0.98%
Fidelity New Millennium Fund 425,000 $59,644,500 0.99%
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF 839,237 $58,771,767 0.04%
iShares Russell 1000 Value ETF 810,587 $56,765,408 0.07%
Schwab U.S. Large-Cap ETF 375,242 $52,661,462 0.07%
Fidelity Blue Chip Growth Fund 953,787 $52,286,603 0.05%
Select Pharmaceuticals Portfolio 372,300 $52,248,582 3.20%
Showing 1–50 of 678 positions
Key facts CIK 1682852 CUSIP 60770K107 13F (30d) 869 filings 784 filers Visit website Investor relations